While systems medicine may promise immense advances for the prevention and treatment of complex diseases, these innovations also pose a number of ethical, psychosocial, legal and economic challenges. The possible consequences that may arise from systemic medicine for clinical everyday life and for the structures of health care are still unclear.

However, the potential consequences of systems medicine for everyday clinical practice and healthcare structures are still unclear. The aim of the consortium is therefore to define ethical, psychosocial, legal and economic benchmarks and, on this basis, to develop a matrix that can serve as a basis for the health system and political management of the identified requirements. To work on this objective, the consortium has access to the world's largest cohort of people at risk of breast and ovarian cancer with the data from the Familial Breast and Ovarian Cancer Consortium.